Aktueller Kenntnisstand und Entwicklungen in der akuten und prophylaktischen Therapie der Migräne

Schriever, J.; Bühlen, M.; Broich, Karl

doi:10.1007/s00103-014-2000-x

Cited by 3 publications

(3 citation statements)

References 41 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Gastroprokinetic drugs are potent inducers of DIP, especially according to reports in Korea [16]. Metoclopramide and levosulpiride are well-known antiemetic and gastroprokinetic agents commonly used for the treatment of nausea, vomiting, gastroparesis, gastroesophageal reflux disease, and migraine [17,18,19,20], and are gastrointestinal prokinetic medications mediated through a blockade of their enteric inhibitory D2 receptors [21]. Besides binding to receptors in the peripheral end organs, thus inducing antiemetic effects via D2 receptor blockade in the area postrema, they also antagonize central D2 receptors, leading to adverse effects including hyperprolactinemia and extrapyramidal side effects.…”

Section: Introductionmentioning

confidence: 99%

Metoclopramide and Levosulpiride Use and Subsequent Levodopa Prescription in the Korean Elderly: The Prescribing Cascade

Huh

Kim

Choi

et al. 2019

JCM

View full text Add to dashboard Cite

The aim of this study was to investigate the prescribing cascade phenomenon of dopaminergic drugs such as levodopa in the management of gastroprokinetic drugs induced parkinsonism. Based on the Korea National Health Insurance Service (NHIS)-Senior Cohort Database, we analyzed patients aged ≥65 years, between 2009 and 2013, who obtained new prescriptions for levodopa through the NHIS during this period. Those who were prescribed levodopa from 2002 to 2008 were excluded, only patients who were prescribed metoclopramide and levosulpiride within 90 days of receiving the levodopa prescription were included. Those who did not receive levodopa were used as a control group for 1:3 age and sex matching. We assessed 1824 and 1197 levodopa cases for metoclopramide and levosulpiride use, respectively. The matched controls for each levodopa case were 5472 and 3591, respectively. We used conditional logistic regression to determine the odds ratio (OR) for initiation of levodopa therapy in patients using metoclopramide and levosulpiride, relative to nonusers, after adjusting for age, sex, and exposure to antipsychotic medication. Both metoclopramide (OR = 3.04; 95% confidence interval, CI, 2.46–3.77) and levosulpiride (OR = 3.32; 95% CI, 2.56–4.3) users were three times more likely to begin using medication containing levodopa, compared to nonusers. Metoclopramide and levosulpiride were frequently prescribed within 90 days of receiving a prescription for levodopa. Before prescribing levodopa, it should be considered whether the adverse event is actually a side effect caused by metoclopramide and levosulpiride.

show abstract

Section: Introductionmentioning

confidence: 99%

Metoclopramide and Levosulpiride Use and Subsequent Levodopa Prescription in the Korean Elderly: The Prescribing Cascade

Huh

Kim

Choi

et al. 2019

JCM

View full text Add to dashboard Cite

show abstract

“…When it occurs, the patient experiences severe pain on one or both sides of the head, accompanied by photophobia, aversion to sound, nausea and other symptoms [2,3] . The common existing treatment methods, such as analgesia and vasodilation, have little effect on migraine and have obvious side effects [4] . Cutting therapy is a treatment method based on the theory of traditional Chinese medicine and is guided by meridians and acupoints.…”

Section: Introductionmentioning

confidence: 99%

“…[2,3] The common existing treatment methods, such as analgesia and vasodilation, have little effect on migraine and have obvious side effects. [4] Cutting therapy is a treatment method based on the theory of traditional Chinese medicine and is guided by meridians and acupoints. As a complementary and alternative medicine, cutting therapy has shown good curative effects on migraine.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of cutting therapy in the treatment of migraine

et al. 2021

View full text Add to dashboard Cite

Background: Migraine is a chronic paroxysmal neurovascular disease in which pain on one or both sides of the head is the main manifestation and is accompanied by other neurological manifestations. Clinical practice has shown that cutting therapy as a complementary alternative medicine can play a role in relieving migraine attacks. However, there is no consensus on the efficacy of cutting treatment in the treatment of migraine. The aim of this study was to conduct a meta-analysis to systematically evaluate the efficacy and safety of cutting therapy in the treatment of migraine. Methods: First, databases were searched for relevant literature. The main databases we searched were PubMed, the Web of Science, MEDLINE, Embase, Cochrane Library, the Chinese National Knowledge Infrastructure, the Chinese Science Journal Database, Wanfang Data, and the Chinese Biomedical Literature Database. The keywords searched were “cutting treatment,” “ traditional Chinese medicine cutting treatment,” and “migraine.” The search was conducted from inception to November 2021. Second, 2 reviewers independently completed the process of study selection, data extraction, risk of bias assessment and data synthesis in strict accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols statement guidelines. Finally, we will use Review Manager Version 5.3 software for meta-analysis. Results: This study will provide the most recent evidence related to the treatment of migraine by cutting therapy. Conclusion: The results of this systematic evaluation will provide an objective evidence-based framework for judging the effectiveness and safety of cutting therapy in the treatment of migraine.

show abstract

Metoclopramide – Induced Extrapyramidal Signs and Symptoms – Brief Review of Literature and Case Report

Valkova¹,

Stamenov²,

Peychinska³

et al. 2014

JofIMAB

View full text Add to dashboard Cite

Aktueller Kenntnisstand und Entwicklungen in der akuten und prophylaktischen Therapie der Migräne

Cited by 3 publications

References 41 publications

Metoclopramide and Levosulpiride Use and Subsequent Levodopa Prescription in the Korean Elderly: The Prescribing Cascade

Metoclopramide and Levosulpiride Use and Subsequent Levodopa Prescription in the Korean Elderly: The Prescribing Cascade

Efficacy and safety of cutting therapy in the treatment of migraine

Metoclopramide – Induced Extrapyramidal Signs and Symptoms – Brief Review of Literature and Case Report

Contact Info

Product

Resources

About